PT  - JOURNAL ARTICLE
AU  - Wen, Yuan Hua
AU  - Sahi, Jasminder
AU  - Urda, Ellen
AU  - Kulkarni, Shaila
AU  - Rose, Kelly
AU  - Zheng, Xianxian
AU  - Sinclair, Jacqueline F.
AU  - Cai, Hongbo
AU  - Strom, Stephen C.
AU  - Kostrubsky, Vsevolod E.
TI  - Effects of Bergamottin on Human and Monkey Drug-Metabolizing Enzymes in Primary Cultured Hepatocytes
AID  - 10.1124/dmd.30.9.977
DP  - 2002 Sep 01
TA  - Drug Metabolism and Disposition
PG  - 977--984
VI  - 30
IP  - 9
4099  - http://dmd.aspetjournals.org/content/30/9/977.short
4100  - http://dmd.aspetjournals.org/content/30/9/977.full
SO  - Drug Metab Dispos2002 Sep 01; 30
AB  - We investigated the effect of bergamottin, a major furanocoumarin in grapefruit juice, on phase I and phase II drug-metabolizing enzymes using cultured human and monkey hepatocytes. Both cultured systems were compared and evaluated for the direct effects of bergamottin as well as control treatments on liver enzymes. Treatment of hepatocytes with 0.1, 1, 5, and 10 μM bergamottin resulted in a concentration-dependent reduction in CYP3A4 activity (40–100%) in both human and monkey cells, as measured by testosterone 6β-hydroxylase activity. Bergamottin was potent at eliciting these inhibitory effects at both basal and induced states of CYP3A. Bergamottin (5 μM) completely inhibited α-naphthoflavone-induced ethoxyresorufinO-dealkylase (EROD) and methoxyresorufinO-dealkylase (MROD) activities in human hepatocytes and caused a 100% decrease in EROD activity in monkey hepatocytes. A 48-h exposure of cultured human hepatocytes to bergamottin resulted in increased levels of immunoreactive CYP3A4, CYP1A1, and CYP1A2 proteins, and CYP3A4, CYP1A1, CYP1A2, CYP2B6, and UDP-glucuronosyl transferase mRNAs. There was only a 20 to 30% reduction in glucuronidation and sulfation of 4-methylumbelliferone in human hepatocytes by 10 μM bergamottin and no effect on conjugation in the monkey hepatocytes. These results suggest that bergamottin causes both inhibition of CYP3A and CYP1A1/2 enzymatic activities and induction of correspondent proteins and mRNAs. U.S. Government